U.S. Metals and Mining Stock News

AerCap Holdings recently reported record quarterly net income and earnings per share, announced a new US$1.00 billion share repurchase program, and raised its 2026 quarterly dividend following strong full-year results. These moves, alongside a sharp increase in earnings guidance and growing institutional interest, highlight management’s confidence in AerCap’s cash generation and its emphasis on returning capital to shareholders. With AerCap’s sharply higher EPS guidance and larger dividend...

Visteon (VC) just packed several updates into its latest report, combining softer 2025 earnings, fresh 2026 sales guidance of US$3.625b to US$3.825b, a higher dividend, and a completed share repurchase program. See our latest analysis for Visteon. The latest report came with a sharp 3.1% one day share price decline and the stock now trades at US$95.67. However, a 14.3% one year total shareholder return contrasts with weaker three and five year total returns, hinting at recovering but...

What the latest 10-K and conference focus tell you about ServisFirst ServisFirst Bancshares (SFBS) recently filed its 2025 Form 10-K and featured at the 2026 Banking Outlook Conference, putting its capital strength, loan and deposit growth plans, and interest rate sensitivities in clear focus for investors. See our latest analysis for ServisFirst Bancshares. At a share price of US$81.01, ServisFirst has given investors a 14.42% 90 day share price return, even though the 1 year total...

Simpson Manufacturing recently detailed in its 2025 10-K that it has opened new production facilities in Columbus, Ohio, and Gallatin, Tennessee, while launching over 50 new products across wood, mass timber, and concrete construction categories. This combination of expanded in-house manufacturing and a broad wave of product development highlights how Simpson is reshaping its cost base and deepening its role in structural building solutions. Next, we’ll examine how these new Ohio and...

MoonLake Immunotherapeutics recently reported full-year 2025 results showing a wider net loss of US$227.32 million and a basic loss per share of US$3.53, while highlighting progress in developing its lead drug candidate, Sonelokimab (SLK), across several inflammatory disease indications. The company’s latest filings and updates emphasize FDA and EMA engagement, multiple positive late-stage trial readouts, and a planned SLK Biologics License Application submission in the second half of 2026...

ResMed (RMD) is expanding its U.S. footprint with a new distribution center in Greenwood, Indiana, planned to begin operations in 2027. The facility aims to widen North American coverage for its sleep and respiratory care products. See our latest analysis for ResMed. ResMed’s new Greenwood distribution hub comes as the stock has eased slightly in the short term, with a 7 day share price return showing a 1.74% decline, while longer term performance looks steadier, including a 1 year total...

In late February 2026, ACI Worldwide reported Q4 2025 revenue of US$481.6 million and full-year revenue of US$1.76 billion, alongside 2026 guidance calling for US$405–US$415 million in Q1 revenue and full-year revenue of US$1.88–US$1.91 billion, implying 7%–9% constant-currency growth. At the same time, ACI highlighted rapid adoption of its cloud-native Connetic platform, including a new UK retail bank deployment unifying major payment rails and AI-driven fraud prevention on a single...

Ingredion recently reported a softer fourth quarter for fiscal 2025, with revenue down year on year and its third consecutive quarter of net income and EPS declines, while also missing analysts’ EBITDA and adjusted operating income expectations. Soon after these results, President and CEO James P. Zallie was appointed Chairman following the former Chair’s resignation and sold 9,958 shares under a pre-set Rule 10b5-1 plan, sharpening investor attention on the company’s leadership and...

The latest stronger than expected US Producer Price Index reading has pushed inflation worries back into focus, pressuring apparel names such as Victoria's Secret (VSCO) as investors reassess risks to discretionary consumer spending and earnings resilience. See our latest analysis for Victoria's Secret. That inflation scare comes after a powerful rebound, with a 30 day share price return of 15.02% and a 90 day share price return of 49.39%, while the 1 year total shareholder return of 161.14%...

Lakeland Financial’s recent update included fourth-quarter 2025 earnings that topped consensus estimates, a 4% increase to its quarterly cash dividend paid in February 2026, and director Welch M Scott’s purchase of 10,000 common shares in late February. These events, alongside mixed analyst opinions and contrasting insider transactions, highlight a tension between external research views and internal confidence at the company. We’ll now examine how the stronger-than-expected quarterly...

Setting the scene for iQIYI (NasdaqGS:IQ) iQIYI (NasdaqGS:IQ) has been under pressure recently, with the share price weaker over the month and past 3 months. This has prompted investors to reassess how its current valuation lines up with recent financial results. See our latest analysis for iQIYI. The latest 1 day share price return of a 6.43% decline extends a weaker trend, with the 30 day share price return down 23.08% and the 1 year total shareholder return down 20.79%. This suggests...

CVS Health (CVS) is in the spotlight after Tennessee Senate Bill 2040 advanced, threatening to force the closure of all company pharmacies in the state. CVS also plans to scale back Medicare Advantage and exit Obamacare exchanges. See our latest analysis for CVS Health. At a share price of US$79.90, CVS has seen a 7.22% 1 month share price return and a modest 2.94% 3 month share price return. Its 1 year total shareholder return of 27.81% points to stronger longer term momentum as investors...

Select Water Solutions (WTTR) is back in focus after a US$175 million secondary equity offering and a new shelf registration, moves the company says will fund water infrastructure projects, potential acquisitions, and possible debt repayment. See our latest analysis for Select Water Solutions. The equity raise and new shelf filing come after a period of strong momentum, with a 90 day share price return of 32.33% and a 5 year total shareholder return of 104.63%, even though the share price...

In February 2026, Zebra Technologies announced that EBI Electric is using its AltiZ 3D sensors and Aurora Imaging software to power Inspector T, an AI-enriched lumber scanning solution that boosts measurement precision and helps mills cut waste while optimizing yield from every plank. The Inspector T system’s ability to detect subtle wood defects and recover up to 5% more usable lumber, with potential annual cost savings near US$750,000 per mill, highlights how Zebra’s machine-vision and AI...

Earnings and Guidance Put Ardelyx in Focus Ardelyx (ARDX) has drawn fresh attention after reporting full year 2025 results and issuing 2026 revenue guidance that highlights expected growth in IBSRELA and XPHOZAH sales. For investors watching the stock, the combination of higher 2025 revenue, a wider net loss, and specific product level guidance for 2026 sets the stage for reassessing the company’s risk and reward profile. See our latest analysis for Ardelyx. At a share price of US$6.55,...

In recent months, Valero Energy reported quarterly earnings that surpassed consensus expectations, advanced plans to idle its Benicia refinery by April 2026, and outlined increased investments in low‑carbon projects, while facing new US biofuel blending proposals that could raise compliance costs for large refiners. These developments highlight how Valero is reshaping its refining footprint and fuel mix at the same time that shifting regulations directly affect its operating economics. We’ll...

Why McKesson’s latest earnings report matters for shareholders McKesson (MCK) shares were in focus after fiscal Q3 2026 results came in ahead of analyst expectations, with management lifting its full-year non-GAAP earnings growth outlook to a range of 17 to 19%, pointing to momentum across oncology and biopharma services. See our latest analysis for McKesson. At a share price of US$987.37, McKesson has seen strong recent momentum, with a 30 day share price return of 18.79% and a 1 year total...

Carpenter Technology (NYSE:CRS) has outlined a CEO succession plan with Brian Malloy scheduled to become Chief Executive Officer on July 1, 2026. Current CEO Tony Thene is expected to transition to the role of Executive Chairman as part of the planned leadership change. Malloy brings operational experience at Carpenter Technology and prior industry leadership that may influence future company priorities. Carpenter Technology enters this planned leadership transition with its shares at...

What the recent move in Diebold Nixdorf means for investors With no single headline event driving trading, Diebold Nixdorf (DBD) has drawn attention after its shares closed at US$80.00, alongside positive month and past 3 months total returns. For investors watching shorter term momentum, the stock shows a 1 day return of about a 3.7% decline, a 7 day gain near 0.6%, roughly 15.9% over the past month, and about 21.9% across the past 3 months. See our latest analysis for Diebold Nixdorf. That...

Franklin Electric (FELE) reported its fourth quarter and full year 2025 results, along with 2026 sales guidance, giving investors fresh detail on recent profitability trends and the company’s forward revenue expectations. See our latest analysis for Franklin Electric. The latest earnings update and 2026 sales guidance arrive after a period where short term momentum has been picking up. The 7 day share price return is 4.51% and the 90 day share price return is 4.55%, while the 1 year total...

In February 2026, Proto Labs launched ProDesk, an all-in-one online platform offering AI-powered real-time quoting, design-for-manufacturability analysis, and collaborative tools across injection molding, CNC machining, and 3D printing to streamline prototyping and production workflows. A key insight is that ProDesk centralizes AI-driven DFM feedback, part management, and engineering support in a single, shareable dashboard for product development and procurement teams, aligning with the...

Gallant, an animal health biotechnology company, recently announced a fulfillment agreement with MWI Animal Health, part of Cencora, to build the first ultra-low temperature cold chain for veterinary medicine and support nationwide distribution of a potential first FDA-approved off-the-shelf veterinary stem cell therapy, pending conditional FDA approval. This partnership highlights Cencora’s growing role in specialized logistics for complex biologics, expanding its capabilities in animal...

What Gilead Sciences stock is offering investors right now Gilead Sciences (GILD) is back on investors’ radar as its shares trade around $148.95, with recent returns over the past month and past 3 months prompting closer attention to its valuation and fundamentals. See our latest analysis for Gilead Sciences. At a share price of $148.95, Gilead Sciences has a 90 day share price return of 20.21% and a 1 year total shareholder return of 32.01%. The 3 year and 5 year total shareholder returns of...

ASGN Incorporated recently filed a US$9.58 million shelf registration for 225,000 common shares tied to its ESOP and announced new Commercial Segment leaders, including Ashish Jandial as President, Commercial North America, and Sangita Singh as President, India and International, following Sean Casey’s retirement and transition to Executive Advisor. These leadership changes, paired with the planned Everforth rebrand and Quinnox acquisition, signal a coordinated push to scale AI-led digital...